AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 311 min read$SNPS

DE GEUS AART sold $11.1M of SNPS

DE GEUS AART (EXECUTIVE CHAIR) sold 25,000 shares of SYNOPSYS INC (SNPS) at $445.55 ($11.14M total) on 2026-08-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DE GEUS AART
Published Aug 31, 2026, 10:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 11:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$SNPS
Neutral
medium confidence
Mentioned
$SNPS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNPSNeutralLow
01

Why it matters

The disclosed sale provides fresh data for traders monitoring insider sentiment.

02

Market read

New insider sale information, modest size, limited immediate market impact.

03

What to watch

Potential tax planning or diversification motives behind the 10b5‑1 execution.

Relevance 6/10Novelty 6/10Timing: filing posted 2026‑08‑31 after market close

Background

Form 4 filings disclose insider transactions; a 10b5‑1 plan indicates pre‑arranged sales.

Company-level read

Ticker impact

$SNPSNeutralMedium confidence
Context

Executive Chair Aart de Geus sold 25,000 shares for $11.1M via a 10b5‑1 plan, reducing his stake to 120,421 shares.

Expected impact

Potential short‑term downward pressure, likely limited to a few basis points.

Evidence & confidence

The sale is a primary Form 4 filing, new information, but $11M is not material for a large‑cap like Synopsys.

Market effects

Sector

Minimal impact on EDA/software sector; insider activity is routine.

Regional

U.S. market only; no broader regional effect.

Global

Low; Synopsys is a global player but the transaction is company‑specific.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event, not a negative signal.

Key entities

  • Company
    Synopsys Inc.

    U.S. listed EDA software provider (ticker SNPS).

  • Executive
    Aart de Geus

    Executive Chair of Synopsys, insider selling shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

SNPS insider trading history →

Related articles

SEP 8
$SNPSMed

SNPS Upgraded by Morgan Stanley -- Price Target Maintained at $5

Morgan Stanley upgraded Synopsys (SNPS) to Overweight, maintaining a $500 price target. The stock is trading at $396.11, which is 39.9% undervalued according to its GF Value™ of $659.20. Synopsys has a GF Score™ of 88/100, indicating strong growth potential but concerns about valuation. Insider activity shows significant selling, with $40.7 million in sales over the last three months.

gurufocus.com2 min
SEP 8
$SNPSMedAI 9/10

How to Play SNPS Stock as Layoffs Hit Synopsys

Synopsys (SNPS) reported Q3 FY2026 earnings with revenue of $2.48B, up 42.4% YoY, and EPS of $3.91, beating estimates. The company raised its full-year outlook. Analysts maintain 'Buy' ratings with price targets up to $633, citing long-term growth potential in semiconductor design.

yahoo.com2 min
SEP 4
$SNPSMedAI 8/10

Synopsys Falls as Strong Results Fail to Clear a High Bar

Synopsys (SNPS) shares fell 5.9% after reporting Q3 revenue of $2.48B and EPS of $3.91, both above guidance. The company raised full-year targets to $9.715B revenue and $15.07 EPS, but investors reacted negatively due to modest outlook increases, restructuring costs, and acquisition-related expenses. Insider sales and mixed hedge fund activity were also noted.

quiverquant.com2 min